UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy

Journal of hypertension, 2014-11, Vol.32 (11), p.2211-2223

2014

Volltextzugriff (PDF)

DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy

Kidney & blood pressure research, 2012-01, Vol.36 (1), p.119-130

2012

Volltextzugriff (PDF)

Renal and Cardiac Effects of DPP-4 Inhibitors from Preclinical Development to Clinical Research

Kidney & blood pressure research, 2012, Vol.36 (1), p.65-84

2012

Volltextzugriff (PDF)

Early urinary and plasma biomarkers for experimental diabetic nephropathy

Clinical laboratory (Heidelberg), 2012-01, Vol.58 (7-8), p.659

2012

Volltextzugriff (PDF)

Renal and Cardiac Effects of DPP4 Inhibitors – from Preclinical Development to Clinical Research

Kidney & blood pressure research, 2012, Vol.36 (1), p.65-84

2012

Volltextzugriff (PDF)

Renal effects of the novel selective adenosine A1 receptor blocker SLV329 in experimental liver cirrhosis in rats

PloS one, 2011-03, Vol.6 (3), p.e17891

2011

Volltextzugriff (PDF)

Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1

Journal of molecular and cellular cardiology, 2010-01, Vol.48 (1), p.230-237

2010

Volltextzugriff (PDF)

Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy

Journal of hypertension, 2014-11, Vol.32 (11), p.2211-2223

2014

Volltextzugriff (PDF)

Skipping of Exon 1 in the KCNQ1 Gene Causes Jervell and Lange-Nielsen Syndrome

The Journal of biological chemistry, 2006-11, Vol.281 (46), p.35397-35403

2006

Volltextzugriff (PDF)

The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy

Kidney international, 2016-05, Vol.89 (5), p.1049-1061

2016

Volltextzugriff (PDF)

ADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiography

Medicine (Baltimore), 2017-02, Vol.96 (6), p.e6065

2017

Volltextzugriff (PDF)

Urinary ET-1 excretion after exposure to radio-contrast media in diabetic patients and patients with preexisting mild impaired renal function

Life sciences (1973), 2014-11, Vol.118 (2), p.440-445

2014

Volltextzugriff (PDF)

Endothelin-Converting Enzyme/Neutral Endopeptidase Inhibitor SLV338 Prevents Hypertensive Cardiac Remodeling in a Blood Pressure–Independent Manner

Hypertension (Dallas, Tex. 1979), 2011-04, Vol.57 (4), p.755-763

2011

Volltextzugriff (PDF)

Urinary ET-1 excretion after exposure to radio-contrast media in diabetic patient and patients with preexisting impaired renal function

Life sciences (1973), 2013-12, Vol.93 (25-26), p.e67-e68

2013

Volltextzugriff (PDF)

Endothelin-1 overexpression restores diastolic function in eNOS knockout mice

Journal of hypertension, 2011-05, Vol.29 (5), p.961-970

2011

Volltextzugriff (PDF)

New evidence for the fetal insulin hypothesis: fetal angiotensinogen M235T polymorphism is associated with birth weight and elevated fetal total glycated hemoglobin at birth

Journal of hypertension, 2010-04, Vol.28 (4), p.732-739

2010

Volltextzugriff (PDF)

Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage

Clinical laboratory (Heidelberg), 2011, Vol.57 (7-8), p.507

2011

Volltextzugriff (PDF)

Renal Effects of the Novel Selective Adenosine A.sub.1 Receptor Blocker SLV329 in Experimental Liver Cirrhosis in Rats

PloS one, 2011-03, Vol.6 (3), p.e17891

2011

Volltextzugriff (PDF)

Urinary cGMP concentrations after exposure to radio-contrast media in patient at risk for contrast media induced nephropathy (CIN) predicts 90-day morbidity and mortality

BMC pharmacology & toxicology, 2013-08, Vol.14 (S1), p.P29-P29, Article P29

2013

Volltextzugriff (PDF)

Maternal and fetal PROGINS progesterone receptor polymorphism reduces the risk for transient tachypnea of the newborn

Clinical laboratory (Heidelberg), 2010, Vol.56 (11-12), p.559

2010

Volltextzugriff (PDF)

Dominant-negative IKs suppression by KCNQ1-ΔF339 potassium channels linked to Romano-Ward syndrome

Cardiovascular research, 2005-08, Vol.67 (3), p.487-497

2005

Volltextzugriff (PDF)

Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels

Naunyn-Schmiedeberg's archives of pharmacology, 2006-06, Vol.373 (3), p.212-220

2006

Volltextzugriff (PDF)

In vitro modulation of HERG channels by organochlorine solvent trichlormethane as potential explanation for proarrhythmic effects of chloroform

Toxicology letters, 2006-08, Vol.165 (2), p.156-166

2006

Volltextzugriff (PDF)

Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome

Cardiovascular research, 2005-08, Vol.67 (3), p.487-497

2005

Volltextzugriff (PDF)

Additional stimulation of sGC on top of standard treatment with ARB`s may offer a new therapeutic approach for the treatment of diabetic nephropathy resistant to ARB treatment alone

BMC pharmacology, 2011-08, Vol.11 (S1), p.P1-P1, Article P1

2011

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Aktive Filter

ThemaMultidisciplinary Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy

DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy

Renal and Cardiac Effects of DPP-4 Inhibitors from Preclinical Development to Clinical Research

Early urinary and plasma biomarkers for experimental diabetic nephropathy

Renal and Cardiac Effects of DPP4 Inhibitors – from Preclinical Development to Clinical Research

Renal effects of the novel selective adenosine A1 receptor blocker SLV329 in experimental liver cirrhosis in rats

Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1

Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy

Skipping of Exon 1 in the KCNQ1 Gene Causes Jervell and Lange-Nielsen Syndrome

The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy

ADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiography

Urinary ET-1 excretion after exposure to radio-contrast media in diabetic patients and patients with preexisting mild impaired renal function

Endothelin-Converting Enzyme/Neutral Endopeptidase Inhibitor SLV338 Prevents Hypertensive Cardiac Remodeling in a Blood Pressure–Independent Manner

Urinary ET-1 excretion after exposure to radio-contrast media in diabetic patient and patients with preexisting impaired renal function

Endothelin-1 overexpression restores diastolic function in eNOS knockout mice

New evidence for the fetal insulin hypothesis: fetal angiotensinogen M235T polymorphism is associated with birth weight and elevated fetal total glycated hemoglobin at birth

Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage

Renal Effects of the Novel Selective Adenosine A.sub.1 Receptor Blocker SLV329 in Experimental Liver Cirrhosis in Rats

Urinary cGMP concentrations after exposure to radio-contrast media in patient at risk for contrast media induced nephropathy (CIN) predicts 90-day morbidity and mortality

Maternal and fetal PROGINS progesterone receptor polymorphism reduces the risk for transient tachypnea of the newborn

Dominant-negative IKs suppression by KCNQ1-ΔF339 potassium channels linked to Romano-Ward syndrome

Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels

In vitro modulation of HERG channels by organochlorine solvent trichlormethane as potential explanation for proarrhythmic effects of chloroform

Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome

Additional stimulation of sGC on top of standard treatment with ARB`s may offer a new therapeutic approach for the treatment of diabetic nephropathy resistant to ARB treatment alone

Aktive Filter

Suchergebnisse filtern